United States · FDA National Drug Code directory
Lidocaine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72603-825_2e79ebee-c652-5f99-e063-6294a90a44ac
- Product NDC
- 72603-825
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Lidocaine hydrochloride
- Labeler
- NorthStar RxLLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250201
- Source listing expiry
- 20261231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE ANHYDROUS — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, MULTI-DOSE in 1 CARTON (72603-825-10) / 50 mL in 1 VIAL, MULTI-DOSE (72603-825-01) · 72603-825-10
- 25 VIAL, MULTI-DOSE in 1 CARTON (72603-825-25) / 50 mL in 1 VIAL, MULTI-DOSE (72603-825-01) · 72603-825-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →